Pfizer files lawsuit of compensation for damage against CJ and Samjin

Published: 2016-04-15 14:53:19

Updated: 2016-04-15 14:53:19

It is now compensation for damage. Pfizer which succeeded in defending the ‘Lyrica’ use patent has decided its next move.

Pfizer Pharmaceuticals Korea filed a lawsuit of compensation for damage about usage of the Lyrica’s(pregabalin) pain(neuropathic pains and fibromyalgia syndrome) indications against CJ HealthCare and Samjin Pharm to the Seoul Central District Court on the 29^th last month. ...

Fees

- Email service daily and homepage access.

$300 per month.
5 Email holders per each company.
Anual contract base.